Error! You must javascript enabled to use this form. Please enable Javascript in your browser. Rare Hematology Market : Recombinant Factor Treatment to Generate Significant Revenues The global rare hematology market is expected to represent a value of over US$ 16,000 Mn by the end of 2022. View full press release Your Name: Your Email: Subject: Question: We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy Send